| Successful prediction of in vivo hepatobiliary clearances and hepatic concentrations of rosuvastatin using sandwich-cultured rat hepatocytes, transporter-expressing cell lines … K Ishida, M Ullah, B Tóth, V Juhasz, JD Unadkat Drug Metabolism and Disposition 46 (1), 66-74, 2018 | 46 | 2018 |
| Positron Emission Tomography Imaging of [11C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of … S Billington, S Shoner, S Lee, K Clark‐Snustad, M Pennington, D Lewis, ... Clinical Pharmacology & Therapeutics 106 (5), 1056-1066, 2019 | 44 | 2019 |
| Intestinal expression and metabolic activity of the CYP3A subfamily in female rats T Aiba, M Yoshinaga, K Ishida, Y Takehara, Y Hashimoto Biological and Pharmaceutical Bulletin 28 (2), 311-315, 2005 | 40 | 2005 |
| Stereoselective oxidation and glucuronidation of carvedilol in human liver and intestinal microsomes K Ishida, S Taira, H Morishita, Y Kayano, M Taguchi, Y Hashimoto Biological and Pharmaceutical Bulletin 31 (6), 1297-1300, 2008 | 34 | 2008 |
| Pharmacokinetic characterization of transcellular transport and drug interaction of digoxin in Caco-2 cell monolayers T Aiba, K Ishida, M Yoshinaga, M Okuno, Y Hashimoto Biological and Pharmaceutical Bulletin 28 (1), 114-119, 2005 | 28 | 2005 |
| Effect of genetic polymorphisms of SLC28A1, ABCG2, and ABCC4 on bioavailability of mizoribine in healthy Japanese males M Fukao, K Ishida, T Sakamoto, M Taguchi, H Matsukura, T Miyawaki, ... Drug metabolism and pharmacokinetics 26 (5), 538-543, 2011 | 27 | 2011 |
| Mechanisms for membrane transport of metformin in human intestinal epithelial Caco‐2 cells A Horie, J Sakata, M Nishimura, K Ishida, M Taguchi, Y Hashimoto Biopharmaceutics & drug disposition 32 (5), 253-260, 2011 | 25 | 2011 |
| Prediction of transporter-mediated rosuvastatin hepatic uptake clearance and drug interaction in humans using proteomics-informed REF approach V Kumar, M Yin, K Ishida, L Salphati, CECA Hop, C Rowbottom, G Xiao, ... Drug Metabolism and Disposition 49 (2), 159-168, 2021 | 24 | 2021 |
| Pharmacokinetic analysis of transcellular transport of levofloxacin across LLC-PK1 and Caco-2 cell monolayers M Takaai, H Suzuki, K Ishida, K Tahara, Y Hashimoto Biological and Pharmaceutical Bulletin 30 (11), 2167-2172, 2007 | 23 | 2007 |
| Pharmacokinetic analysis of transcellular transport of quinidine across monolayers of human intestinal epithelial Caco-2 cells K Ishida, M Takaai, Y Hashimoto Biological and Pharmaceutical Bulletin 29 (3), 522-526, 2006 | 23 | 2006 |
| Population pharmacokinetics of mizoribine in adult recipients of renal transplantation K Ishida, M Okamoto, M Ishibashi, Y Hashimoto Clinical and experimental nephrology 15, 900-906, 2011 | 19 | 2011 |
| Membrane transport mechanisms of quinidine and procainamide in renal LLC-PK1 and intestinal LS180 cells M Masago, M Takaai, J Sakata, A Horie, T Ito, K Ishida, M Taguchi, ... Biological and Pharmaceutical Bulletin 33 (8), 1407-1412, 2010 | 19 | 2010 |
| Membrane transport mechanisms of mizoribine in the rat intestine and human epithelial LS180 cells K Ishida, M Takaai, A Yotsutani, M Taguchi, Y Hashimoto Biological and Pharmaceutical Bulletin 32 (4), 741-745, 2009 | 19 | 2009 |
| Transport Kinetics, Selective Inhibition, and Successful Prediction of In Vivo Inhibition of Rat Hepatic Organic Anion Transporting Polypeptides K Ishida, M Ullah, B Tóth, V Juhasz, JD Unadkat Drug Metabolism and Disposition 46 (9), 1251-1258, 2018 | 18 | 2018 |
| Plasma concentrations of tadalafil in children with pulmonary arterial hypertension H Kohno, F Ichida, K Hirono, S Ozawa, N Yoshimura, T Nakamura, ... Therapeutic drug monitoring 36 (5), 576-583, 2014 | 16 | 2014 |
| Effect of salt intake on bioavailability of mizoribine in healthy Japanese males K Ishida, M Fukao, H Watanabe, M Taguchi, T Miyawaki, H Matsukura, ... Drug metabolism and pharmacokinetics 28 (1), 75-80, 2013 | 16 | 2013 |
| Contribution of Na+-independent nucleoside transport to ribavirin uptake in the rat intestine and human epithelial LS180 cells M Takaai, H Morishita, K Ishida, M Taguchi, Y Hashimoto European journal of pharmacology 601 (1-3), 61-65, 2008 | 16 | 2008 |
| Variability of bioavailability and intestinal absorption characteristics of bisoprolol K Ishida, A Horie, M Nishimura, M Taguchi, N Fujii, T Nozawa, H Inoue, ... Drug metabolism and pharmacokinetics 28 (6), 491-496, 2013 | 15 | 2013 |
| Population pharmacokinetics of mizoribine in pediatric recipients of renal transplantation K Ishida, O Motoyama, S Shishido, K Tsuzuki, Y Hashimoto Clinical and experimental nephrology 16, 799-804, 2012 | 15 | 2012 |
| Membrane transport mechanisms of choline in human intestinal epithelial LS180 cells A Horie, K Ishida, Y Watanabe, K Shibata, Y Hashimoto Biopharmaceutics & drug disposition 35 (9), 532-542, 2014 | 14 | 2014 |
